Waterfront Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Waterfront Wealth's BMY Position: Q3 2026 in Review
Waterfront Wealth increased its Bristol-Myers Squibb (BMY) stake by 0.33% in Q3 2026, buying an estimated $7.08K and bringing the position to 33,560 shares worth $2.07M. The position accounts for 0.33% of the portfolio, ranked #86.
Waterfront Wealth first reported a position in BMY in Q2 2021 and has held it in 14 quarters since. 2,253 funds tracked by Wall St. Rank hold BMY as of Q3 2026.
- Waterfront Wealth held 33,560 shares of Bristol-Myers Squibb worth $2.07M as of Q3 2026.
- Waterfront Wealth bought 112 Bristol-Myers Squibb shares in Q3 2026, an estimated $7.08K.
- Bristol-Myers Squibb made up 0.33% of Waterfront Wealth's portfolio in Q3 2026, its #86 holding.
- Waterfront Wealth first reported a position in Bristol-Myers Squibb in Q2 2021 and has held it in 14 quarters since.
- 2,253 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.
Based on Waterfront Wealth's 13F filing for Q3 2026, filed 3 Nov 2026.